A recent survey of 255 Life Sciences Clinincal Operations executives: Of the 34% that have an RBM initiative in place, 68% still use latent, manual spreadsheets. Only 8% indicated that they have successfully automated their RBM program.
This case study details how one successful Clinical Operations team automated their next generation risk and centralized monitoring program. After only 10 weeks, they were continuously and efficiently optimizing KRIs in enrollment, compliance, site productivity to lower risk and increase speed to a quality result.
There may be many networking opportunities at the How One Clinical Operations Team Returned 100% of Studies to Within Risk Threshold: A Next Generation Monitoring Case Study. Find out more in the event details below.
|Conference/Event Dates:||05/26/2016 - 05/26/2016|
|Primary Industry:||Clinical Pharmacology|
|Other Industries:||Clinical Pharmacology, Professional Healthcare|
|Audience:||Clinical Operations and Data Management Professionals
Clinical Trial/Clinical Study Management
Clinical Research, Technology and Business Professionals
Medical and Scientific Professionals
Chief Medical Officer
Chief Science Officer
|Booth Size||Booth Cost||Available Amenities|
|Marketing Vehicles Allowed:||n/a|
|Other Booth Sizes Available: n/a|
How do I show up here?
Add a note here, it is only visible by you.